Occurrence and behavior of the chiral anti-inflammatory drug naproxen in an aquatic environment

Environmental Toxicology and Chemistry

Volumn 33, Issue 12, 2014, Pages 2671-2678

  Suzuki, Toshinari ^a   Kosugi, Yuki ^a   Hosaka, Mitsugu ^a   Nishimura, Tetsuji ^b   Nakae, Dai ^a  

^a NATIONAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^b TEIKYO HEISEI UNIVERSITY   (Japan)

Author keywords

Chiral inversion; Enantiomeric fraction; Naproxen; Sewage treatment plant

Indexed keywords

EFFLUENTS; ENANTIOMERS; METABOLITES; PROPIONIC ACID; RIVERS;

ANTI-INFLAMMATORY DRUGS; AQUATIC ENVIRONMENTS; CHIRAL INVERSION; ENANTIOMERIC FRACTIONS; LABORATORY CONDITIONS; NAPROXENS; RAPID DEGRADATION; UNTREATED SEWAGE;

SEWAGE TREATMENT PLANTS;

DRUG METABOLITE; IBUPROFEN; NAPROXEN; RAIN; RIVER WATER; ANTIINFLAMMATORY AGENT; SEWAGE; WATER POLLUTANT;

ACTIVATED SLUDGE; AQUATIC ENVIRONMENT; BIODEGRADATION; CONCENTRATION (COMPOSITION); DRUG; EFFLUENT; FRACTIONATION; METABOLITE; ORGANIC ACID; PHOTODEGRADATION; RAINFALL; RIVER WATER; SEWAGE TREATMENT;

ACTIVATED SLUDGE; AQUATIC ENVIRONMENT; ARTICLE; BIODEGRADABILITY; BIODEGRADATION; CHIRALITY; CONTROLLED STUDY; DECARBOXYLATION; DRUG TRANSFORMATION; EFFLUENT; ENANTIOMER; ENANTIOMERIC RATIO; HALF LIFE TIME; INCUBATION TIME; IRRADIATION; MOLECULAR WEIGHT; PHOTODEGRADATION; PRIORITY JOURNAL; RATE CONSTANT; RIVER BASIN; SEWAGE TREATMENT PLANT; SOLID PHASE EXTRACTION; ANALYSIS; CHEMISTRY; ENVIRONMENTAL MONITORING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; PHOTOLYSIS; RIVER; SEWAGE; STEREOISOMERISM; TANDEM MASS SPECTROMETRY; WATER POLLUTANT;

HONSHU; JAPAN; KANTO; TAMA RIVER;

ANTI-INFLAMMATORY AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENVIRONMENTAL MONITORING; NAPROXEN; PHOTOLYSIS; RIVERS; SEWAGE; STEREOISOMERISM; TANDEM MASS SPECTROMETRY; WASTE DISPOSAL, FLUID; WATER POLLUTANTS, CHEMICAL;

EID: 84929130592     PISSN: 07307268     EISSN: 15528618     Source Type: Journal    
DOI: 10.1002/etc.2741     Document Type: Article

References (39)

1. Kallenborn R, Huhnerfuss H. 2001. Chiral Environmental Pollutants. Springer-Verlag, Berlin, Germany.
2. Garrison AW. 2006. Probing the enantioselectivity of chiral pesticides. Environ Sci Technol 40:16-23.
3. Janak K, Covac A, Voorspoels S, Becher G. 2005. Hexabromocyclododecane in marine species from Western Scheldt Estuary: Diastereoisomer- and enantiomer-specific accumulation. Environ Sci Technol 39:1987-1994.
4. Daughton C, Ternes TA. 1999. Pharmaceuticals and personal care products in the environment: Agents of subtle change? Environ Health Perspect 107:907-938.
5. Kolpin DW, Furlong ET, Meyer MT, Thruman EM, Zaugg SD, Barber LB, Buxton HT. 2002. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: A national reconnaissance. Environ Sci Technol 36:1202-1211.
6. Renner R. 1996. Chiral compounds show promise as environmental tracers. Environ Sci Technol 30:16A-17A.
7. Zipper C, Suter MJF, Haderein SB, Gruhl M, Kohler HPE. 1998. Changes in the enantiomeric ratio of (R)- to (S)-mecoprop indicate in situ biodegradation of this chiral herbicide in a polluted aquifer. Environ Sci Technol 32:2070-2076.
8. Jones WJ, Mazur CS, Kenneke JF, Garrison AW. 2007. Enantioselective microbial transformation of the phenylpyrazole insecticide Fipronil in anoxic sediments. Environ Sci Technol 41:8301-8307.
9. Buser HR, Poiger T, Muller MD. 1999. Occurrence and environmental behavior of the chiral pharmaceutical drug ibuprofen in surface water and in wastewater. Environ Sci Technol 33:2529-2535.
10. Fono L, Sedlak D. 2005. Use of the chiral pharmaceutical propranolol to identify sewage discharge into surface waters. Environ Sci Technol 39:9244-9252.
11. Tomlinson RV, Ringold HJ, Qureshi MC, Forchielli E. 1972. Relationship between inhibition of prostaglandin synthesis and drug efficacy: Support for the current theory on mode of action of aspirin-like drugs. Biochem Biophys Res Commun 46:552-559.
12. Hutt AJ, Caldwell J. 1983. The metabolic chiral inversion of 2-arylpropanoic acids - A novel route with pharmacological consequences. J Pharm Pharmacol 35:693-704.
13. Strong M. 1999. FDA policy and regulation of stereoisomers: Paradigm shift and the future of safer, more effective drugs. Food Drug Law J 54:463-487.
14. Harrison IT, Lewis B, Nelson P, Rooks W, Roszkowski A, Tomolonis A, Fried JH. 1970. Nonsteroidal antiinflammatory agents. I. 6-Substituted 2-naphthylacetc acid. J Med Chem 13:203-205.
15. Sugawara Y, Fujiwara M, Miura Y, Hayashida K, Takahashi T. 1978. Studies of the fate of NAP. II. Metabolic fate in various animals and man. Chem Pharm Bull 26:3312-3321.
16. Goto J, Goto N, Nambara T. 1982. Separation and determination of NAP enantiomers in serum by high-performance liquid chromatography. J Chromatogr 239:559-564.
17. Anderson JV, Hansen SH. 1992. Simultaneous determination of (R)- and (S)-NAP and (R)- and (S)-6-O-desmethylNAP by high-performance liquid chromatography on a chiral-AGP column. J Chromatogr 577:362-365.
18. Packer JL, Wener JJ, Latch DE, McNeil K, Arnold WA. 2003. Photochemical fate of pharmaceuticals in the environment: NAP, diclofenac, clofibric acid, and ibuprofen. Aquat Sci 65:342-351.
19. Jones OAH, Voulvoulis N, Lester JN. 2002. Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Res 36:5013-5022.
20. Vieno NM, Harkki H, Tuhkanen T, Kronberg L. 2007. Occurrence of pharmaceuticals in river water and their elimination in a pilot-scale drinking water treatment plant. Environ Sci Technol 41:5077-5084.
21. Zhang S, Zhang Q, Darisaw S, Ehie O, Wang G. 2007. Simultaneous quantification of polycyclic aromatic hydrocarbons (PAHs), polychlorinated biphenyls (PCBs), and pharmaceuticals and personal care products (PPCPs) in Mississippi river water, in New Orleans, Louisiana, USA. Chemosphere 66:1057-1069.
22. Tixier C, Singer HP, Oellers S, Muller SR. 2003. Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen and NAP in surface waters. Environ Sci Technol 37:1061-1068.
23. Ternes TA. 1998. Occurrence of drugs in German sewage treatment plants and rivers. Water Res 32:3245-3260.
24. Nakada N, Tanishima T, Shinohara H, Kiri K, Takada H. 2006. Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment. Water Res 40:3297-3303.
25. Mark JB, Rebecca A, Trenholm BJ, Vanderford JC, Holady DS, Shane AS. 2009. Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water. Environ Sci Technol 43:597-603.
26. Quintana JB, Weiss S, Reemtsma T. 2005. Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor. Water Res 39:2654-2664.
27. He A, Rosazza JPN. 2003. Microbial transformations of S-NAP by Aspergillus niger ATCC 9142. Pharmazie 58:420-422.
28. Da-Fang Z, Lu S, Lei L, Hai-Hua H. 2003. Microbial transformation of NAP by Cunninghamella species. Acta Pharmacol Sin 24:442-447.
29. 2 in sealed vessels (headspace test). OECD Guidelines for the Testing of Chemicals. Paris France.
30. Kimura K, Hara H, Watanabe Y. 2007. Elimination of selected acidic pharmaceuticals from municipal wastewater by an activated sludge system and membrane bioreactors. Environ Sci Technol 41:3708-3714.
31. Nakada N, Komori K, Suzuki Y. 2005. Occurrence and fate of anti-inflammatory drugs in wastewater treatment plants in Japan. Environ Sci 12:359-369.
32. Carballa M, Omil F, Lema JM, Llompart M, Garcia-Jares C, Rodriguez I, Gomez M, Ternes T. 2004. Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Res 38:2918-2926.
33. Qurie M, Khamis M, Malek F, Nlr S, BufoJihad Abbadi SA, Scrano SA, Karaman R. 2014. Stability and removal of naproxen and its metabolite by advanced membrane wastewater treatment plant and micelle-Clay complex. Clean Soil Air Water 42:594-600.
34. Vieno NM, Tuhkanen T, Kronberg L. 2005. Seasonal variation in the occurrence of pharmaceuticals in effluents from a sewage treatment plant and in the recipient water. Environ Sci Technol 39:8220-8226.
35. Lindqvist N, Tuhkanen T, Kronberg L. 2005. Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters. Water Res 39:2219-2228.
36. Bosca F, Marin ML, Miranda MA. 2001. Photoreactivity of the nonsteroidal anti-inflammatory 2-arylpropipnic acids with photosensitizing side effects. Photochem Photobiol 74:637-655.
37. Lin AYC, Reinhard M. 2005. Photodegradation of common environmental pharmaceuticals and estrogens in river water. Environ Toxicol Chem 24:1303-1309.
38. Felis E, Marciocha D, Surmacz-Gorska J, Miksch K. 2007. Photochemical degradation of NAP in the aquatic environment. Water Sci Technol 55:281-286.
39. Nakada N, Kiri K, Shinohara H, Harada A, Kuroda K, Takizawa S, Takada H. 2008. Evaluation of pharmaceuticals and personal care products as water-soluble molecular markers of sewage. Environ Sci Technol 42:6347-6353.